Lobbying Filing Details

Total Spending

$2,090,000

Activities

15

Lobbyists

24

Gov't Entities

195

Filing Information
Filing UUID:
cb96899c-8b16-4e5a-8832-ff5323ffbb48
Type:
Q3 - 3rd Quarter - Report
Period:
2014 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 20, 2014 at 9:53 PM
Income:
$0
Expenses:
$2,090,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Brent DelMonte, Vice President for Federal Government Relations
Registrant
BIOTECHNOLOGY INNOVATION ORGANIZATION

Trade Association

Washington, District of Columbia
Client
BIOTECHNOLOGY INNOVATION ORGANIZATION
District of Columbia, United States of America
Lobbying Activities (15)
Activity 1
Agriculture

EPA Regulations on Agricultural Biotechnology
Efficient Science-Based Review of Biotech ProductsGenetically Engineered (GE) Animals
FDA Approval
H.R. 4800/S. 2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Amendment on GE Salmon Labeling

Review and Labeling of Food Derived From Biotechnology
H.R. 4432: Safe and Accurate Food Labeling Act

Funding for the USDA
H.R. 4800/S. 2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
Like-minded Countries Initiatives

Funding for Biomass Crop Assistance Program
H.R. 4800/S. 2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Transatlantic Trade and Investment Partnership
Ag-Biotech Issues

USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
USDA Decision on GE Crops Environmental Impact Statement

Lobbyists (8)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • MS. ANNA KATHERINE WEINSTEIN
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • JOSEPH DAMOND
  • CATHLEEN ENRIGHT
  • MR. MATTHEW O'MARA
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 2
Animals

Genetically Engineered (GE) Animals
FDA Approval
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Amendment on GE Salmon Labeling

Lobbyists (5)
  • MR. BRENT ALAN DELMONTE
  • MS. ANNA KATHERINE WEINSTEIN
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • CATHLEEN ENRIGHT
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 3
Budget/Appropriations

Funding for the USDA
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

Funding for FDA
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Funding for Centers for Disease Control and Prevention Vaccine Programs
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

Funding for Biomass Crop Assistance Program
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Sequestration of PDUFA Fees
S. 1413: FDA User Fee Protection Act

Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Funding for Biofuels
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Funding for Biorefineries
Implementation of the Agricultural Act of 2014
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Lobbyists (12)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • TOM DILENGE
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • RINA SINGH
  • KELLY CAPPIO
  • MS. A. CATHARINE HARRIS
  • ERICK LUTT
  • DERRICK M WHITE
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 4
Consumer Issues/Safety/Products

Sunshine Act Implementation

21st Century Cures InitiativeGenetically Engineered (GE) Animals
FDA Approval
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Amendment on GE Salmon Labeling

Review and Labeling of Food Derived From Biotechnology
H.R. 4432: Safe and Accurate Food Labeling Act

Funding for FDA
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Drug Evaluation and Review
Compassionate Use/Expanded Access
Implementation of the FDA Safety and Innovation Act
Special Medical Use/Limited Population Drug

Biosimilars
Colombia Biologics Regulations
Implementation of Affordable Care Act
Interchangeability and Pharmacy Substitution
Naming

USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
USDA Decision on GE Crops Environmental Impact Statement

Lobbyists (17)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • TOM DILENGE
  • LAUREL TODD
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • KELLY CAPPIO
  • CATHLEEN ENRIGHT
  • MS. A. CATHARINE HARRIS
  • JEFFREY PETERS
  • DERRICK M WHITE
  • MR. MATTHEW O'MARA
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 5
Copyright/Patent/Trademark

Patenting of Humanitarian Technologies
S. 712: Patents for Humanity Program Improvement Act of 2013Patent Reform
H.R. 3309: Innovation Act of 2013
S. 1013: Patent Abuse Reduction Act of 2013
S. 1720: Patent Transparency and Improvements Act of 2013
S. 866: Patent Quality Improvement Act of 2013
Targeting Rogue and Opaque Letters (TROL) Act of 2014 (Discussion Draft)
FTC Regulation of Patent Demand Letters (Senate Commerce Committee Discussion Draft)

Intellectual Property International Enforcement
Compulsory Licensing
India Issues

TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals

Transatlantic Trade and Investment Partnership
Intellectual Property Issues

Patenting of Biological Inventions

Lobbyists (8)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • TOM DILENGE
  • HANSJORG SAUER
  • MS. ANNA KATHERINE WEINSTEIN
  • JOSEPH DAMOND
  • MR. CHARLES H FRITTS
  • DERRICK M WHITE
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 6
Energy/Nuclear

Funding for Biofuels
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Biofuels (Non-Funding)
Accelerated Depreciation Extension
Climate Change Benefits
Production Tax Credit Extension
Renewable Fuel Standard
H.R. 3758: Second Generation Biofuel Extension Act of 2013
S. 2260: EXPIRE Act of 2014

Renewable Chemicals/Bio-based Products (Non-Funding)
Implementation of the Agriculture Act of 2014
Bonus Depreciation for Renewable Chemical Facilities
S. 2260: EXPIRE Act of 2014

Funding for Biomass Crop Assistance Program
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Funding for Biorefineries
Implementation of the Agricultural Act of 2014
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Lobbyists (8)
  • MR. BRENT ALAN DELMONTE
  • TOM DILENGE
  • MS. ANNA KATHERINE WEINSTEIN
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • RINA SINGH
  • MR. CHARLES H FRITTS
  • ERICK LUTT
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 7
Food Industry (safety, labeling, etc.)

Review and Labeling of Food Derived From Biotechnology
H.R. 4432: Safe and Accurate Food Labeling ActGenetically Engineered (GE) Animals
FDA Approval
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Amendment on GE Salmon Labeling

Lobbyists (5)
  • MR. BRENT ALAN DELMONTE
  • MS. ANNA KATHERINE WEINSTEIN
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • CATHLEEN ENRIGHT
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 8
Fuel/Gas/Oil

Funding for Biofuels
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Biofuels (Non-Funding)
Accelerated Depreciation Extension
Climate Change Benefits
Production Tax Credit Extension
Renewable Fuel Standard
H.R. 3758: Second Generation Biofuel Extension Act of 2013
S. 2260: EXPIRE Act of 2014

Renewable Chemicals/Bio-based Products (Non-Funding)
Implementation of the Agriculture Act of 2014
Bonus Depreciation for Renewable Chemical Facilities
S. 2260: EXPIRE Act of 2014

Funding for Biomass Crop Assistance Program
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Funding for Biorefineries
Implementation of the Agricultural Act of 2014
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R.4923: Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Lobbyists (8)
  • MR. BRENT ALAN DELMONTE
  • TOM DILENGE
  • MS. ANNA KATHERINE WEINSTEIN
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • RINA SINGH
  • MR. CHARLES H FRITTS
  • ERICK LUTT
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 9
Health Issues

Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015Biosimilars
Naming
Colombia Biologics Regulations
Implementation of Affordable Care Act
Interchangeability and Pharmacy Substitution

Funding for Centers for Disease Control and Prevention Vaccine Programs
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

Vaccine Access/Financing
Implementation of Affordable Care Act
S.2694: Ensuring Access to Primary Care for Women and Children Act

340B Drug Pricing Program
Implementation of Affordable Care Act
Program Implementation & Oversight
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

Funding for FDA
H.R. 4800/S.2389: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
CMS Proposed Rule on Protected Classes

Sequestration of PDUFA Fees
S. 1413: FDA User Fee Protection Act

Drug Evaluation and Review
Compassionate Use/Expanded Access
Special Medical Use/Limited Population Drug
Implementation of the FDA Safety and Innovation Act

Orphan Drug Act Tax Credit

Clinical Trial Data Sharing and Disclosure
EU Policies
Canadian Policies

Sunshine Act Implementation

Affordable Care Act Implementation
Third Party Support of Patient Premiums and Cost-Sharing Obligations

21st Century Cures InitiativeTransPacific Partnership
Regulatory Transparency
Data and Intellectual Property Protections for Pharmaceuticals

Transatlantic Trade and Investment Partnership
Regulatory Harmonization
Reimbursement Transparency
Intellectual Property Issues

Lobbyists (19)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • TOM DILENGE
  • SHELLY MUI-LIPNIK
  • HANSJORG SAUER
  • LAUREL TODD
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • JOSEPH DAMOND
  • KELLY CAPPIO
  • CHARLES CRAIN
  • MR. CHARLES H FRITTS
  • MS. A. CATHARINE HARRIS
  • JEFFREY PETERS
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 10
Homeland Security

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

Lobbyists (6)
  • MR. BRENT ALAN DELMONTE
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • KELLY CAPPIO
  • DERRICK M WHITE
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 11
Medical/Disease Research/Clinical Labs

Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

21st Century Cures Initiative

Lobbyists (14)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • TOM DILENGE
  • LAUREL TODD
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • KELLY CAPPIO
  • MS. A. CATHARINE HARRIS
  • JEFFREY PETERS
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 12
Medicare/Medicaid

21st Century Cures Initiative
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program: CMS Proposed Rule on Protected Classes

Lobbyists (12)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • SARA RADCLIFFE
  • TOM DILENGE
  • LAUREL TODD
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • KELLY CAPPIO
  • MS. A. CATHARINE HARRIS
  • JEFFREY PETERS
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 13
Small Business

Sarbanes Oxley Section 404 (b)
Mandatory Audit Firm Rotation
H.R. 1564/S. 1526: The Audit Integrity and Job Protection ActCapital Formation Investment Incentives
Reform of Capital Gains Rules
Reform of Net Operating Loss Rules
Reform of Passive Loss Rules
S. 1658: The Start-up Jobs and Innovation Act
H.R. 4855: The PARTNER Act
S.2715: The COMPETE Act

Expansion of Exemption under SEC Regulation A
H.R. 4565: Startup Capital Modernization Act
Proposed SEC Rule on Reg A+

Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
H.R. 2629: The Fostering Innovation Act

XBRL Exemption for Small Public Companies
H.R. 4164: Small Company Disclosure Simplification Act
H.R. 5405: The Promoting Job Creation and Reducing Small Business Burdens Act

Stock Exchange Tick Size
H.R. 3448: The Small Cap Liquidity Reform Act
H.R. 1952: The Spread Pricing Liquidity Act

Capital Market Enhancements
H.R. 3623: Improving Access to Capital for Emerging Growth Companies Act
H.R. 4568: Small Business Freedom to Grow Act
H.R. 4569: Disclosure Modernization and Simplification Act
H.R. 4571: To direct the SEC to revise its rules so as to increase the threshold amount for requiring issuers to
provide certain disclosures relating to compensatory benefits plans
H.R. 4697: To require the SEC to revise the definition of a WKSI to reduce the worldwide market value threshold
under the definition

Lobbyists (8)
  • MR. BRENT ALAN DELMONTE
  • TOM DILENGE
  • SHELLY MUI-LIPNIK
  • MS. ANNA KATHERINE WEINSTEIN
  • CHARLES CRAIN
  • MR. CHARLES H FRITTS
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 14
Taxation/Internal Revenue Code

Bonus Depreciation
S. 2260: EXPIRE Act of 2014Tax Reform

Orphan Drug Act Tax Credit

Renewable Chemicals/Bio-based Products
Bonus Depreciation for Renewable Chemical Facilities
S. 2260: EXPIRE Act of 2014

Biofuels
Accelerated Depreciation Extension
Production Tax Credit Extension
H.R. 3758: Second Generation Biofuel Extension Act of 2013
S. 2260: EXPIRE Act of 2014

Research & Development Tax Credit Reforms
Extension
Permanency
H.R. 4438: American Research & Competitiveness Act of 2014
S. 2260: EXPIRE Act of 2014
S. 2715: The COMPETE Act
S.193: The Start-up Innovation Credit Act

Capital Formation Investment Incentives
Reform of Capital Gains Rules
Reform of Net Operating Loss Rules
Reform of Passive Loss Rules
H.R. 4855: The PARTNER Act
S. 1658: The Start-up Jobs and Innovation Act
S. 2715: The COMPETE Act

Controlled Foreign Corporation Look-Through Rule Extension
S. 2260: EXPIRE Act of 2014

Inversions
H.R.4870: Department of Defense Appropriations Act for FY 2015
H.R.5016: Financial Services and General Government Appropriations Act for FY 2015

Lobbyists (12)
  • MR. BRENT ALAN DELMONTE
  • TOM DILENGE
  • SHELLY MUI-LIPNIK
  • MS. ANNA KATHERINE WEINSTEIN
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • RINA SINGH
  • CHARLES CRAIN
  • MR. CHARLES H FRITTS
  • ERICK LUTT
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more
Activity 15
Trade (domestic/foreign)

Intellectual Property International Enforcement
Compulsory Licensing
IndiaForeign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
Like-minded Countries Initiatives

TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Regulatory Transparency

Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
Intellectual Property Issues
Regulatory Harmonization
Reimbursement Transparency

Biosimilars
Colombia Biologics Regulations

Clinical Trial Data Sharing and Disclosure
EU Policies
Canadian Policies

Lobbyists (11)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • TOM DILENGE
  • HANSJORG SAUER
  • MR. DANA MAURICE O'BRIEN JR
  • JOSEPH DAMOND
  • CATHLEEN ENRIGHT
  • MR. CHARLES H FRITTS
  • JEFFREY PETERS
  • DERRICK M WHITE
  • MR. MATTHEW O'MARA
Government Entities (13)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Natl Security Council (NSC)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 8 more

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.